Aerosol delivery of an immunomodulator (interferon-γ 1b) within mouse lungs

Neil R. MacIntyre (Durham, United States of America), Neil MacIntyre, Sanjay Bhardwaj, Rohinton Toddywala

Source: International Congress 2015 – Interstitial lung diseases I
Session: Interstitial lung diseases I
Session type: Thematic Poster Session
Number: 812
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Neil R. MacIntyre (Durham, United States of America), Neil MacIntyre, Sanjay Bhardwaj, Rohinton Toddywala. Aerosol delivery of an immunomodulator (interferon-γ 1b) within mouse lungs. Eur Respir J 2015; 46: Suppl. 59, 812

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Anti-fibrotic role of inhaled interferon-γ in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients?
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Initiation of anti-TNF therapy within 3 weeks of LTBI treatment in patients with immune-mediated inflammatory diseases
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014

Interferon gamma release assays based on M. tuberculosis-specific antigens (IGRAs) in sarcoidosis patients
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015

Aerosolized interferon-gamma (IFN-γ) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Year: 2007


CD8-response associates with active tuberculosis and TB2-tube response in the QuantiFERON-TB-Plus kit
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Significance of interferon gamma-inducible chemokines in pleural effusions
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015

Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Pulmonary Disease in Pregnancy (Asthma, CF, TB etc.)
Source: Respipedia Article
Year: 2018

Pulmonary tuberculosis (TB) as a complication of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009


Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014


Treatment of Idiopathic pulmonary fibrosis with interferon beta - our experience in seven patients
Source: Eur Respir J 2003; 22: Suppl. 45, 44s
Year: 2003

Use of an ELISPOT interferon-gamma release assay for screening of end-stage renal failure contacts in haemodialysis centres
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

Diagnosis of latent tuberculosis infection in children with the useof different immunological methods
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


LATE-BREAKING ABSTRACT: The performance of flow cytometry in the diagnosis of latent tuberculosis infection in patients under treatment with anti-TNFa and other biological agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013


The value of immunological methods in the diagnosis of tuberculosis in patients with HIV
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of mycobacterium tuberculosis infection
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014


What is the best test to detect latent tuberculosis infection in sarcoidosis patients? – Comparison between two commercially available interferon gamma release assays
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013